SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-002706
Filing Date
2014-06-05
Accepted
2014-06-05 06:45:14
Documents
10
Period of Report
2014-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060514.htm 8-K 21146
2 EXHIBIT 99.1 exh_991.htm EX-99.1 7533
3 exh991_01.jpg GRAPHIC 114684
4 exh991_02.jpg GRAPHIC 101066
5 exh991_03.jpg GRAPHIC 101442
6 exh991_04.jpg GRAPHIC 121213
7 exh991_05.jpg GRAPHIC 109632
8 exh991_06.jpg GRAPHIC 120674
9 exh991_07.jpg GRAPHIC 133383
10 exh991_08.jpg GRAPHIC 99021
  Complete submission text file 0001171843-14-002706.txt   1272243
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 14892446
SIC: 2834 Pharmaceutical Preparations